Dose Effect of Poractant Alfa in Neonatal RDS: Analysis of Combined Data from Three Prospective Studies

Aim: To evaluate the effect of the initial dose of poractant alfa on clinical outcomes in neonatal respiratory distress syndrome (RDS) and to assess adherence to treatment guidelines recommending a dose of 200 mg/kg. Methods: Records of neonates who received poractant alfa with a less invasive techn...

Descripción completa

Detalles Bibliográficos
Autores principales: Królak-Olejnik, Barbara, Hożejowski, Roman, Szczapa, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732442/
https://www.ncbi.nlm.nih.gov/pubmed/33330292
http://dx.doi.org/10.3389/fped.2020.603716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732442/
https://www.ncbi.nlm.nih.gov/pubmed/33330292
http://dx.doi.org/10.3389/fped.2020.603716

Ejemplares similares